[Mesoglycan in acute and chronic venous insufficiency of the legs].
Fifty-eight patients with acute and chronic pathology of the lower limbs were treated with daily oral doses of 96 mg of mesoglycan, a drug having antithrombotic and fibrinolytic properties. After a 3-months trial both clinical picture and instrumental parameters were found to be improved.
Sangrigoli
V
V
Carrà
G
G
Lazzara
N
N
Micale
F
F
Puleo
M G
MG
Bonaccorsi
R
R
D000208:Acute Disease; D000328:Adult; D002908:Chronic Disease; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012039:Regional Blood Flow; D014463:Ultrasonography; D014689:Venous Insufficiency / Q000188:drug therapy* / Q000503:physiopathology
D006025:Glycosaminoglycans; C040617:mesoglycan
Il mesoglicano nell'insufficienza venosa acuta e cronica degli arti inferiori.